

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 5.81563631 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.81563631 |
| 3 | iron ion import (GO:0097286) | 5.75563971 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.32212050 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.32212050 |
| 6 | cytoplasmic mRNA processing body assembly (GO:0033962) | 5.16913230 |
| 7 | Golgi transport vesicle coating (GO:0048200) | 4.87097284 |
| 8 | COPI coating of Golgi vesicle (GO:0048205) | 4.87097284 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 4.73190175 |
| 10 | nuclear pore complex assembly (GO:0051292) | 4.54467562 |
| 11 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 4.35247166 |
| 12 | protein carboxylation (GO:0018214) | 4.20751766 |
| 13 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.20751766 |
| 14 | biotin metabolic process (GO:0006768) | 4.18728531 |
| 15 | intestinal cholesterol absorption (GO:0030299) | 4.15499190 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.11216313 |
| 17 | nuclear pore organization (GO:0006999) | 4.00844694 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 4.00350616 |
| 19 | COPII vesicle coating (GO:0048208) | 3.93677671 |
| 20 | bile acid biosynthetic process (GO:0006699) | 3.92969460 |
| 21 | import into cell (GO:0098657) | 3.90208585 |
| 22 | complement activation, alternative pathway (GO:0006957) | 3.87909187 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 3.84474284 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 3.83180270 |
| 25 | tyrosine metabolic process (GO:0006570) | 3.83168701 |
| 26 | urea cycle (GO:0000050) | 3.82469257 |
| 27 | urea metabolic process (GO:0019627) | 3.82469257 |
| 28 | negative regulation of fibrinolysis (GO:0051918) | 3.80535778 |
| 29 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 3.78408992 |
| 30 | regulation of protein activation cascade (GO:2000257) | 3.78348074 |
| 31 | regulation of RNA export from nucleus (GO:0046831) | 3.77984778 |
| 32 | regulation of fibrinolysis (GO:0051917) | 3.77280457 |
| 33 | tryptophan catabolic process (GO:0006569) | 3.76569797 |
| 34 | indole-containing compound catabolic process (GO:0042436) | 3.76569797 |
| 35 | indolalkylamine catabolic process (GO:0046218) | 3.76569797 |
| 36 | tryptophan metabolic process (GO:0006568) | 3.74994458 |
| 37 | kynurenine metabolic process (GO:0070189) | 3.71030043 |
| 38 | cysteine metabolic process (GO:0006534) | 3.69860437 |
| 39 | homocysteine metabolic process (GO:0050667) | 3.69238460 |
| 40 | bile acid metabolic process (GO:0008206) | 3.61868793 |
| 41 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.58031173 |
| 42 | regulation of complement activation (GO:0030449) | 3.57996821 |
| 43 | triglyceride homeostasis (GO:0070328) | 3.52259675 |
| 44 | acylglycerol homeostasis (GO:0055090) | 3.52259675 |
| 45 | histone H3-K36 demethylation (GO:0070544) | 3.51324244 |
| 46 | reverse cholesterol transport (GO:0043691) | 3.48339994 |
| 47 | nitrogen cycle metabolic process (GO:0071941) | 3.47858105 |
| 48 | glyoxylate metabolic process (GO:0046487) | 3.47291710 |
| 49 | carnitine shuttle (GO:0006853) | 3.47253798 |
| 50 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.43715781 |
| 51 | aromatic amino acid family metabolic process (GO:0009072) | 3.42914142 |
| 52 | endocrine pancreas development (GO:0031018) | 3.42798308 |
| 53 | negative regulation of complement activation (GO:0045916) | 3.42553732 |
| 54 | negative regulation of glycogen biosynthetic process (GO:0045719) | 3.41351911 |
| 55 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.40796703 |
| 56 | cellular response to ethanol (GO:0071361) | 3.39660576 |
| 57 | bile acid and bile salt transport (GO:0015721) | 3.38861621 |
| 58 | coenzyme catabolic process (GO:0009109) | 3.38819561 |
| 59 | regulation of cholesterol homeostasis (GO:2000188) | 3.28248965 |
| 60 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.27944972 |
| 61 | histone H3-K9 demethylation (GO:0033169) | 3.26028365 |
| 62 | intestinal absorption (GO:0050892) | 3.25777288 |
| 63 | lysine catabolic process (GO:0006554) | 3.25147062 |
| 64 | lysine metabolic process (GO:0006553) | 3.25147062 |
| 65 | branching involved in prostate gland morphogenesis (GO:0060442) | 3.23378834 |
| 66 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.21992977 |
| 67 | Golgi to endosome transport (GO:0006895) | 3.21719264 |
| 68 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.20978536 |
| 69 | plasma lipoprotein particle remodeling (GO:0034369) | 3.20789718 |
| 70 | protein-lipid complex remodeling (GO:0034368) | 3.20789718 |
| 71 | macromolecular complex remodeling (GO:0034367) | 3.20789718 |
| 72 | phospholipid efflux (GO:0033700) | 3.19909187 |
| 73 | cellular ketone body metabolic process (GO:0046950) | 3.18450197 |
| 74 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.16714862 |
| 75 | regulation of triglyceride catabolic process (GO:0010896) | 3.15883401 |
| 76 | cholesterol efflux (GO:0033344) | 3.13946024 |
| 77 | histone lysine demethylation (GO:0070076) | 3.12872477 |
| 78 | Golgi organization (GO:0007030) | 3.12421688 |
| 79 | cellular modified amino acid catabolic process (GO:0042219) | 3.11799610 |
| 80 | 4-hydroxyproline metabolic process (GO:0019471) | 3.11785585 |
| 81 | pore complex assembly (GO:0046931) | 3.11590166 |
| 82 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.11376619 |
| 83 | ER overload response (GO:0006983) | 3.10477408 |
| 84 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.08826050 |
| 85 | plasma lipoprotein particle clearance (GO:0034381) | 3.08573251 |
| 86 | histone H3-K4 trimethylation (GO:0080182) | 3.08295542 |
| 87 | alpha-amino acid catabolic process (GO:1901606) | 3.07662241 |
| 88 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.06089184 |
| 89 | indolalkylamine metabolic process (GO:0006586) | 3.05152584 |
| 90 | drug transmembrane transport (GO:0006855) | 3.04839653 |
| 91 | protein retention in ER lumen (GO:0006621) | 3.03849055 |
| 92 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.03567808 |
| 93 | short-chain fatty acid metabolic process (GO:0046459) | 3.03358375 |
| 94 | phospholipid homeostasis (GO:0055091) | 3.02675225 |
| 95 | serine family amino acid catabolic process (GO:0009071) | 3.02553025 |
| 96 | fatty acid transmembrane transport (GO:1902001) | 3.02332720 |
| 97 | glutamate metabolic process (GO:0006536) | 3.01346707 |
| 98 | negative regulation of protein activation cascade (GO:2000258) | 3.00851583 |
| 99 | histone demethylation (GO:0016577) | 3.00293700 |
| 100 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.99281366 |
| 101 | positive regulation of nuclease activity (GO:0032075) | 2.98037469 |
| 102 | cellular amino acid catabolic process (GO:0009063) | 2.95397005 |
| 103 | endocrine hormone secretion (GO:0060986) | 2.95200164 |
| 104 | establishment of protein localization to Golgi (GO:0072600) | 2.95165480 |
| 105 | regulation of cholesterol esterification (GO:0010872) | 2.93489792 |
| 106 | amino-acid betaine metabolic process (GO:0006577) | 2.92294095 |
| 107 | interkinetic nuclear migration (GO:0022027) | 2.91855804 |
| 108 | drug catabolic process (GO:0042737) | 2.89670305 |
| 109 | positive regulation of glycolytic process (GO:0045821) | 2.89049678 |
| 110 | macroautophagy (GO:0016236) | 2.87815515 |
| 111 | negative regulation of lipase activity (GO:0060192) | 2.87709905 |
| 112 | negative regulation of sterol transport (GO:0032372) | 2.84395429 |
| 113 | negative regulation of cholesterol transport (GO:0032375) | 2.84395429 |
| 114 | early endosome to late endosome transport (GO:0045022) | 2.83238407 |
| 115 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.81957133 |
| 116 | transcytosis (GO:0045056) | 2.81933681 |
| 117 | cellular glucuronidation (GO:0052695) | 2.81840892 |
| 118 | valine metabolic process (GO:0006573) | 2.81217738 |
| 119 | positive regulation of lipid catabolic process (GO:0050996) | 2.80321109 |
| 120 | lipoprotein metabolic process (GO:0042157) | 2.79362032 |
| 121 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.79321367 |
| 122 | regulation of bile acid biosynthetic process (GO:0070857) | 2.78198504 |
| 123 | exocrine pancreas development (GO:0031017) | 2.77397504 |
| 124 | ketone body metabolic process (GO:1902224) | 2.77273033 |
| 125 | protein targeting to vacuole (GO:0006623) | 2.76794583 |
| 126 | protein targeting to lysosome (GO:0006622) | 2.76794583 |
| 127 | establishment of protein localization to vacuole (GO:0072666) | 2.76794583 |
| 128 | protein targeting to Golgi (GO:0000042) | 2.76736711 |
| 129 | carnitine transmembrane transport (GO:1902603) | 2.75288012 |
| 130 | fatty acid oxidation (GO:0019395) | 2.74833345 |
| 131 | ER-nucleus signaling pathway (GO:0006984) | 2.74722339 |
| 132 | cellular response to unfolded protein (GO:0034620) | 2.73520034 |
| 133 | vesicle coating (GO:0006901) | 2.73407376 |
| 134 | histone H3-K4 methylation (GO:0051568) | 2.73225904 |
| 135 | Golgi to plasma membrane transport (GO:0006893) | 2.72922555 |
| 136 | fibrinolysis (GO:0042730) | 2.72716047 |
| 137 | peptide hormone processing (GO:0016486) | 2.71564199 |
| 138 | plasma lipoprotein particle assembly (GO:0034377) | 2.71029103 |
| 139 | negative regulation of glycogen metabolic process (GO:0070874) | 2.70590943 |
| 140 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.69983164 |
| 141 | complement activation, classical pathway (GO:0006958) | 2.69427481 |
| 142 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.69127195 |
| 143 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.68332330 |
| 144 | lipid oxidation (GO:0034440) | 2.68174943 |
| 145 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.65075384 |
| 146 | carnitine transport (GO:0015879) | 2.64859066 |
| 147 | amino-acid betaine transport (GO:0015838) | 2.64859066 |
| 148 | epoxygenase P450 pathway (GO:0019373) | 2.63795202 |
| 149 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.62067742 |
| 150 | protein demethylation (GO:0006482) | 2.60786423 |
| 151 | protein dealkylation (GO:0008214) | 2.60786423 |
| 152 | intracellular lipid transport (GO:0032365) | 2.60554682 |
| 153 | mitotic sister chromatid cohesion (GO:0007064) | 2.59067115 |
| 154 | coronary vasculature morphogenesis (GO:0060977) | 2.58271830 |
| 155 | endoplasmic reticulum organization (GO:0007029) | 2.57728533 |
| 156 | stress granule assembly (GO:0034063) | 2.57383459 |
| 157 | mRNA modification (GO:0016556) | 2.56275261 |
| 158 | omega-hydroxylase P450 pathway (GO:0097267) | 2.54842761 |
| 159 | phospholipid translocation (GO:0045332) | 2.53462737 |
| 160 | lipid translocation (GO:0034204) | 2.53462737 |
| 161 | NLS-bearing protein import into nucleus (GO:0006607) | 2.52057544 |
| 162 | regulation of protein polyubiquitination (GO:1902914) | 2.48543493 |
| 163 | peptidyl-lysine dimethylation (GO:0018027) | 2.47719565 |
| 164 | anterior/posterior axis specification, embryo (GO:0008595) | 2.45732032 |
| 165 | regulation of ARF protein signal transduction (GO:0032012) | 2.45603815 |
| 166 | intestinal epithelial cell development (GO:0060576) | 2.45359218 |
| 167 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.45132267 |
| 168 | linoleic acid metabolic process (GO:0043651) | 2.44459453 |
| 169 | peptidyl-lysine trimethylation (GO:0018023) | 2.44225826 |
| 170 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.42211835 |
| 171 | positive regulation of macroautophagy (GO:0016239) | 2.42046519 |
| 172 | negative regulation of glucose import (GO:0046325) | 2.41455183 |
| 173 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.40572214 |
| 174 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.37664336 |
| 175 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.37519112 |
| 176 | negative regulation of humoral immune response (GO:0002921) | 2.36834453 |
| 177 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.32262018 |
| 178 | quaternary ammonium group transport (GO:0015697) | 2.31435674 |
| 179 | ovulation from ovarian follicle (GO:0001542) | 2.31386966 |
| 180 | pre-miRNA processing (GO:0031054) | 2.30368221 |
| 181 | peptidyl-threonine modification (GO:0018210) | 2.27944202 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.51833396 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.09801044 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.39789784 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.22533453 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.84957240 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.34063084 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.31382879 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.00613769 |
| 9 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.70095747 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.66354823 |
| 11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.56701157 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.49246522 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.22100014 |
| 14 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.19411029 |
| 15 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.99100906 |
| 16 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.97931617 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.96906248 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.89177449 |
| 19 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.80761310 |
| 20 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.80137736 |
| 21 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.79733021 |
| 22 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.74853716 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.74293797 |
| 24 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.70251429 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.67885674 |
| 26 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.67310324 |
| 27 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.66858711 |
| 28 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.66709541 |
| 29 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.52684444 |
| 30 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.44440109 |
| 31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.42916950 |
| 32 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.40910240 |
| 33 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40891533 |
| 34 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.38565514 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38229334 |
| 36 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.37616376 |
| 37 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.37616376 |
| 38 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.37615476 |
| 39 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36650393 |
| 40 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.36502074 |
| 41 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36350793 |
| 42 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35513070 |
| 43 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.34760433 |
| 44 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.33953664 |
| 45 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.33826218 |
| 46 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.30864325 |
| 47 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29196312 |
| 48 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.27034543 |
| 49 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.26905013 |
| 50 | TP53_16413492_ChIP-PET_HCT116_Human | 1.26835180 |
| 51 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25246368 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24575949 |
| 53 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.23245000 |
| 54 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.23080205 |
| 55 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.22948994 |
| 56 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.22518248 |
| 57 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.22232256 |
| 58 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.21490914 |
| 59 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.20309602 |
| 60 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.18866158 |
| 61 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.17382549 |
| 62 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.16505656 |
| 63 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.15940201 |
| 64 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15884235 |
| 65 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.15357417 |
| 66 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.15230236 |
| 67 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.13055115 |
| 68 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.11505320 |
| 69 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.08274232 |
| 70 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.08175435 |
| 71 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07578287 |
| 72 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.06184930 |
| 73 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.04916267 |
| 74 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.04802541 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04130090 |
| 76 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03292892 |
| 77 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.02889329 |
| 78 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.02889329 |
| 79 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.02888514 |
| 80 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02282978 |
| 81 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01050949 |
| 82 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00288725 |
| 83 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.99578528 |
| 84 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.99258723 |
| 85 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.97507796 |
| 86 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97393084 |
| 87 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.96626589 |
| 88 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.96448266 |
| 89 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.96331978 |
| 90 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.95763705 |
| 91 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95446239 |
| 92 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.94985211 |
| 93 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.93598662 |
| 94 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.92511724 |
| 95 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.92068184 |
| 96 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.90415643 |
| 97 | STAT3_23295773_ChIP-Seq_U87_Human | 0.90082963 |
| 98 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89729243 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89422204 |
| 100 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.89042855 |
| 101 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89002899 |
| 102 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.88021760 |
| 103 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86340409 |
| 104 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85888057 |
| 105 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85195710 |
| 106 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.84062494 |
| 107 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.83807534 |
| 108 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.82625819 |
| 109 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.82512220 |
| 110 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.81811528 |
| 111 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.81248603 |
| 112 | RXR_22108803_ChIP-Seq_LS180_Human | 0.81110919 |
| 113 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.80955754 |
| 114 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.79121507 |
| 115 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77237650 |
| 116 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.76981695 |
| 117 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.76435251 |
| 118 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.76182627 |
| 119 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.74218497 |
| 120 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.74155734 |
| 121 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.72941319 |
| 122 | GATA1_19941826_ChIP-Seq_K562_Human | 0.72512542 |
| 123 | TCF4_23295773_ChIP-Seq_U87_Human | 0.71808383 |
| 124 | AR_25329375_ChIP-Seq_VCAP_Human | 0.71629343 |
| 125 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.71349425 |
| 126 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.70664250 |
| 127 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70357898 |
| 128 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.70079544 |
| 129 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.69784428 |
| 130 | AR_19668381_ChIP-Seq_PC3_Human | 0.69678761 |
| 131 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.69210776 |
| 132 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.68206292 |
| 133 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.67990468 |
| 134 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.67990468 |
| 135 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.67914604 |
| 136 | P300_19829295_ChIP-Seq_ESCs_Human | 0.67856840 |
| 137 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.67583675 |
| 138 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.67333693 |
| 139 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.67312688 |
| 140 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.67033629 |
| 141 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.66988684 |
| 142 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.66428626 |
| 143 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.66062040 |
| 144 | CJUN_26792858_Chip-Seq_BT549_Human | 0.65946697 |
| 145 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.65434656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002009_preneoplasia | 6.20862272 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.20470667 |
| 3 | MP0005360_urolithiasis | 5.33264798 |
| 4 | MP0005365_abnormal_bile_salt | 5.17035456 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 4.92119828 |
| 6 | MP0003252_abnormal_bile_duct | 3.93441557 |
| 7 | MP0003195_calcinosis | 3.79360278 |
| 8 | MP0008057_abnormal_DNA_replication | 3.70991088 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 3.60510839 |
| 10 | MP0002166_altered_tumor_susceptibility | 3.39329881 |
| 11 | MP0004858_abnormal_nervous_system | 2.96926208 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.87968488 |
| 13 | MP0010352_gastrointestinal_tract_polyps | 2.80289628 |
| 14 | MP0003868_abnormal_feces_composition | 2.72547213 |
| 15 | MP0004233_abnormal_muscle_weight | 2.65226794 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.64179085 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.64156266 |
| 18 | MP0005083_abnormal_biliary_tract | 2.63990602 |
| 19 | MP0002006_tumorigenesis | 2.38004028 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 2.32860923 |
| 21 | MP0004043_abnormal_pH_regulation | 2.25625703 |
| 22 | MP0000013_abnormal_adipose_tissue | 2.13976068 |
| 23 | MP0002877_abnormal_melanocyte_morpholog | 2.13846287 |
| 24 | MP0000569_abnormal_digit_pigmentation | 2.10828939 |
| 25 | MP0002693_abnormal_pancreas_physiology | 2.03794797 |
| 26 | MP0005332_abnormal_amino_acid | 2.02518989 |
| 27 | MP0002837_dystrophic_cardiac_calcinosis | 2.00277723 |
| 28 | MP0002909_abnormal_adrenal_gland | 1.99990731 |
| 29 | MP0005220_abnormal_exocrine_pancreas | 1.98373939 |
| 30 | MP0005076_abnormal_cell_differentiation | 1.98290144 |
| 31 | MP0001944_abnormal_pancreas_morphology | 1.97176829 |
| 32 | MP0002118_abnormal_lipid_homeostasis | 1.91890546 |
| 33 | MP0009840_abnormal_foam_cell | 1.90706617 |
| 34 | MP0002138_abnormal_hepatobiliary_system | 1.80799541 |
| 35 | MP0002078_abnormal_glucose_homeostasis | 1.79126528 |
| 36 | MP0000609_abnormal_liver_physiology | 1.68656917 |
| 37 | MP0003283_abnormal_digestive_organ | 1.67837244 |
| 38 | MP0003890_abnormal_embryonic-extraembry | 1.63503813 |
| 39 | MP0010386_abnormal_urinary_bladder | 1.55810843 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.48990887 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.45336512 |
| 42 | MP0003787_abnormal_imprinting | 1.41824776 |
| 43 | MP0009643_abnormal_urine_homeostasis | 1.41147531 |
| 44 | MP0010234_abnormal_vibrissa_follicle | 1.39040657 |
| 45 | MP0004019_abnormal_vitamin_homeostasis | 1.38562325 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.35194525 |
| 47 | MP0000003_abnormal_adipose_tissue | 1.33533250 |
| 48 | MP0005503_abnormal_tendon_morphology | 1.28002231 |
| 49 | MP0005319_abnormal_enzyme/_coenzyme | 1.26842456 |
| 50 | MP0003123_paternal_imprinting | 1.26451331 |
| 51 | MP0004264_abnormal_extraembryonic_tissu | 1.25750294 |
| 52 | MP0004036_abnormal_muscle_relaxation | 1.23558847 |
| 53 | MP0009697_abnormal_copulation | 1.21724055 |
| 54 | MP0002896_abnormal_bone_mineralization | 1.21234964 |
| 55 | MP0002928_abnormal_bile_duct | 1.20202998 |
| 56 | MP0005379_endocrine/exocrine_gland_phen | 1.18622208 |
| 57 | MP0003315_abnormal_perineum_morphology | 1.18567194 |
| 58 | MP0003091_abnormal_cell_migration | 1.17839453 |
| 59 | MP0003941_abnormal_skin_development | 1.17218916 |
| 60 | MP0008438_abnormal_cutaneous_collagen | 1.15823073 |
| 61 | MP0005310_abnormal_salivary_gland | 1.15750666 |
| 62 | MP0003221_abnormal_cardiomyocyte_apopto | 1.15351815 |
| 63 | MP0005535_abnormal_body_temperature | 1.13524404 |
| 64 | MP0000537_abnormal_urethra_morphology | 1.12051733 |
| 65 | MP0005058_abnormal_lysosome_morphology | 1.10513416 |
| 66 | MP0001765_abnormal_ion_homeostasis | 1.10440858 |
| 67 | MP0002876_abnormal_thyroid_physiology | 1.09834544 |
| 68 | MP0005670_abnormal_white_adipose | 1.09447035 |
| 69 | MP0001764_abnormal_homeostasis | 1.06672038 |
| 70 | MP0003183_abnormal_peptide_metabolism | 1.03326558 |
| 71 | MP0000627_abnormal_mammary_gland | 1.02727255 |
| 72 | MP0003121_genomic_imprinting | 1.02633744 |
| 73 | MP0003950_abnormal_plasma_membrane | 1.02359223 |
| 74 | MP0005395_other_phenotype | 1.01661288 |
| 75 | MP0005636_abnormal_mineral_homeostasis | 1.01228926 |
| 76 | MP0003632_abnormal_nervous_system | 1.01083909 |
| 77 | MP0004130_abnormal_muscle_cell | 1.01044270 |
| 78 | MP0005409_darkened_coat_color | 1.00981413 |
| 79 | MP0005451_abnormal_body_composition | 1.00383184 |
| 80 | MP0003045_fibrosis | 0.99662711 |
| 81 | MP0003953_abnormal_hormone_level | 0.98913022 |
| 82 | MP0005334_abnormal_fat_pad | 0.98425054 |
| 83 | MP0008961_abnormal_basal_metabolism | 0.94011030 |
| 84 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93556054 |
| 85 | MP0004084_abnormal_cardiac_muscle | 0.93334448 |
| 86 | MP0005448_abnormal_energy_balance | 0.93327244 |
| 87 | MP0001915_intracranial_hemorrhage | 0.92573661 |
| 88 | MP0004272_abnormal_basement_membrane | 0.91610879 |
| 89 | MP0009115_abnormal_fat_cell | 0.91539848 |
| 90 | MP0002168_other_aberrant_phenotype | 0.89871379 |
| 91 | MP0005375_adipose_tissue_phenotype | 0.88777548 |
| 92 | MP0001756_abnormal_urination | 0.88582408 |
| 93 | MP0002971_abnormal_brown_adipose | 0.88342733 |
| 94 | MP0002088_abnormal_embryonic_growth/wei | 0.88122920 |
| 95 | MP0002108_abnormal_muscle_morphology | 0.87014674 |
| 96 | MP0010307_abnormal_tumor_latency | 0.86742105 |
| 97 | MP0003984_embryonic_growth_retardation | 0.85693355 |
| 98 | MP0005408_hypopigmentation | 0.85192620 |
| 99 | MP0005621_abnormal_cell_physiology | 0.84817898 |
| 100 | MP0003959_abnormal_lean_body | 0.83839905 |
| 101 | MP0009642_abnormal_blood_homeostasis | 0.83543168 |
| 102 | MP0000371_diluted_coat_color | 0.82424794 |
| 103 | MP0003566_abnormal_cell_adhesion | 0.81048808 |
| 104 | MP0000604_amyloidosis | 0.79670254 |
| 105 | MP0000598_abnormal_liver_morphology | 0.78387018 |
| 106 | MP0000678_abnormal_parathyroid_gland | 0.78368736 |
| 107 | MP0009703_decreased_birth_body | 0.78166682 |
| 108 | MP0000733_abnormal_muscle_development | 0.77786853 |
| 109 | MP0004197_abnormal_fetal_growth/weight/ | 0.76289294 |
| 110 | MP0003329_amyloid_beta_deposits | 0.76158315 |
| 111 | MP0002086_abnormal_extraembryonic_tissu | 0.75674398 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.75554754 |
| 113 | MP0000230_abnormal_systemic_arterial | 0.73528501 |
| 114 | MP0005084_abnormal_gallbladder_morpholo | 0.73363347 |
| 115 | MP0000639_abnormal_adrenal_gland | 0.72680619 |
| 116 | MP0001984_abnormal_olfaction | 0.72670729 |
| 117 | MP0000538_abnormal_urinary_bladder | 0.71501631 |
| 118 | MP0006138_congestive_heart_failure | 0.70919314 |
| 119 | MP0005164_abnormal_response_to | 0.67398186 |
| 120 | MP0005666_abnormal_adipose_tissue | 0.66156060 |
| 121 | MP0000432_abnormal_head_morphology | 0.65732757 |
| 122 | MP0003172_abnormal_lysosome_physiology | 0.65506322 |
| 123 | MP0001661_extended_life_span | 0.64768263 |
| 124 | MP0001672_abnormal_embryogenesis/_devel | 0.63054411 |
| 125 | MP0005380_embryogenesis_phenotype | 0.63054411 |
| 126 | MP0003879_abnormal_hair_cell | 0.62017403 |
| 127 | MP0008775_abnormal_heart_ventricle | 0.61303797 |
| 128 | MP0005645_abnormal_hypothalamus_physiol | 0.58467935 |
| 129 | MP0005646_abnormal_pituitary_gland | 0.58206634 |
| 130 | MP0006054_spinal_hemorrhage | 0.57970529 |
| 131 | MP0009384_cardiac_valve_regurgitation | 0.55043698 |
| 132 | MP0003656_abnormal_erythrocyte_physiolo | 0.54291472 |
| 133 | MP0005187_abnormal_penis_morphology | 0.54146143 |
| 134 | MP0000613_abnormal_salivary_gland | 0.52478307 |
| 135 | MP0000462_abnormal_digestive_system | 0.51945125 |
| 136 | MP0009763_increased_sensitivity_to | 0.51760677 |
| 137 | MP0003690_abnormal_glial_cell | 0.51707663 |
| 138 | MP0002060_abnormal_skin_morphology | 0.51705852 |
| 139 | MP0002295_abnormal_pulmonary_circulatio | 0.51520918 |
| 140 | MP0005275_abnormal_skin_tensile | 0.50681354 |
| 141 | MP0004185_abnormal_adipocyte_glucose | 0.47384341 |
| 142 | MP0005647_abnormal_sex_gland | 0.47311011 |
| 143 | MP0001502_abnormal_circadian_rhythm | 0.46670513 |
| 144 | MP0002638_abnormal_pupillary_reflex | 0.46071725 |
| 145 | MP0001881_abnormal_mammary_gland | 0.45816051 |
| 146 | MP0003633_abnormal_nervous_system | 0.44805773 |
| 147 | MP0002069_abnormal_eating/drinking_beha | 0.44558500 |
| 148 | MP0005248_abnormal_Harderian_gland | 0.43709229 |
| 149 | MP0001299_abnormal_eye_distance/ | 0.43186375 |
| 150 | MP0002090_abnormal_vision | 0.42576123 |
| 151 | MP0010368_abnormal_lymphatic_system | 0.42386269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.61773202 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.58490923 |
| 3 | Hypoglycemic coma (HP:0001325) | 5.26617831 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.17914945 |
| 5 | Hyperinsulinemic hypoglycemia (HP:0000825) | 5.06490623 |
| 6 | Hypoglycemic seizures (HP:0002173) | 4.80632840 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.72687724 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.68276422 |
| 9 | Xanthomatosis (HP:0000991) | 4.66137935 |
| 10 | Sparse lateral eyebrow (HP:0005338) | 4.47642802 |
| 11 | Abnormality of the intrinsic pathway (HP:0010989) | 4.32819406 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.32207367 |
| 13 | Ketoacidosis (HP:0001993) | 4.30174174 |
| 14 | Conjugated hyperbilirubinemia (HP:0002908) | 4.29763664 |
| 15 | Ketosis (HP:0001946) | 4.20986953 |
| 16 | Hyperglycemia (HP:0003074) | 4.06973055 |
| 17 | Hypobetalipoproteinemia (HP:0003563) | 3.99141849 |
| 18 | Papillary thyroid carcinoma (HP:0002895) | 3.98947387 |
| 19 | Symptomatic seizures (HP:0011145) | 3.93613451 |
| 20 | Complement deficiency (HP:0004431) | 3.81588199 |
| 21 | Hyperlipoproteinemia (HP:0010980) | 3.74401630 |
| 22 | Neonatal hypoglycemia (HP:0001998) | 3.65670603 |
| 23 | Lip pit (HP:0100267) | 3.51795327 |
| 24 | Epidermoid cyst (HP:0200040) | 3.42605348 |
| 25 | Fat malabsorption (HP:0002630) | 3.38580416 |
| 26 | Skin nodule (HP:0200036) | 3.36799386 |
| 27 | Dysmetric saccades (HP:0000641) | 3.28134547 |
| 28 | Abnormality of the fingertips (HP:0001211) | 3.24824045 |
| 29 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.22432808 |
| 30 | Hypolipoproteinemia (HP:0010981) | 3.21976381 |
| 31 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.20078214 |
| 32 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.20078214 |
| 33 | Joint hemorrhage (HP:0005261) | 3.14952208 |
| 34 | Hyperglycinemia (HP:0002154) | 3.14137145 |
| 35 | Hypoalphalipoproteinemia (HP:0003233) | 3.02824022 |
| 36 | Overgrowth (HP:0001548) | 3.00834201 |
| 37 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.00030547 |
| 38 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.99111352 |
| 39 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.97447831 |
| 40 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.86819936 |
| 41 | Late onset (HP:0003584) | 2.79900184 |
| 42 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.79884819 |
| 43 | Macroorchidism (HP:0000053) | 2.78092507 |
| 44 | Hyperammonemia (HP:0001987) | 2.73521937 |
| 45 | Abnormality of complement system (HP:0005339) | 2.63860508 |
| 46 | Abnormality of methionine metabolism (HP:0010901) | 2.55942786 |
| 47 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.55332339 |
| 48 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.52655137 |
| 49 | Abnormality of glycine metabolism (HP:0010895) | 2.52655137 |
| 50 | Gonadotropin excess (HP:0000837) | 2.51812788 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.51738413 |
| 52 | Hyperglycinuria (HP:0003108) | 2.49995353 |
| 53 | Myocardial infarction (HP:0001658) | 2.48743245 |
| 54 | Hypercholesterolemia (HP:0003124) | 2.46845668 |
| 55 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.45696450 |
| 56 | Gout (HP:0001997) | 2.45530009 |
| 57 | Anal stenosis (HP:0002025) | 2.41345887 |
| 58 | Generalized aminoaciduria (HP:0002909) | 2.40281621 |
| 59 | Narrow palate (HP:0000189) | 2.38788270 |
| 60 | Flat acetabular roof (HP:0003180) | 2.38614470 |
| 61 | Hyperbilirubinemia (HP:0002904) | 2.37492437 |
| 62 | Volvulus (HP:0002580) | 2.32860132 |
| 63 | Thyroid carcinoma (HP:0002890) | 2.30739991 |
| 64 | Protuberant abdomen (HP:0001538) | 2.30739387 |
| 65 | Mucopolysacchariduria (HP:0008155) | 2.30010883 |
| 66 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.30010883 |
| 67 | Retinal atrophy (HP:0001105) | 2.29078470 |
| 68 | Mitral stenosis (HP:0001718) | 2.27969666 |
| 69 | Abnormality of the axillary hair (HP:0100134) | 2.26018124 |
| 70 | Abnormality of secondary sexual hair (HP:0009888) | 2.26018124 |
| 71 | Deep philtrum (HP:0002002) | 2.19478246 |
| 72 | Insulin resistance (HP:0000855) | 2.19345896 |
| 73 | Truncal obesity (HP:0001956) | 2.18866265 |
| 74 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.18351304 |
| 75 | Coarse hair (HP:0002208) | 2.17205684 |
| 76 | Cubitus valgus (HP:0002967) | 2.16135519 |
| 77 | Large for gestational age (HP:0001520) | 2.15170110 |
| 78 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.14879239 |
| 79 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.14879239 |
| 80 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.14879239 |
| 81 | Persistence of primary teeth (HP:0006335) | 2.14498195 |
| 82 | Hypochromic microcytic anemia (HP:0004840) | 2.14463692 |
| 83 | Steatorrhea (HP:0002570) | 2.13799608 |
| 84 | Curly hair (HP:0002212) | 2.13399574 |
| 85 | Hepatocellular carcinoma (HP:0001402) | 2.13345867 |
| 86 | Hyperventilation (HP:0002883) | 2.12654799 |
| 87 | Azoospermia (HP:0000027) | 2.12108624 |
| 88 | Heterotopia (HP:0002282) | 2.09863428 |
| 89 | Pheochromocytoma (HP:0002666) | 2.08818614 |
| 90 | Dysostosis multiplex (HP:0000943) | 2.07196973 |
| 91 | Pancreatitis (HP:0001733) | 2.05935151 |
| 92 | Acute myeloid leukemia (HP:0004808) | 2.05429432 |
| 93 | Abnormality of nucleobase metabolism (HP:0010932) | 2.03390209 |
| 94 | Irritability (HP:0000737) | 2.02661990 |
| 95 | Enlarged kidneys (HP:0000105) | 2.01612119 |
| 96 | Germ cell neoplasia (HP:0100728) | 1.99513929 |
| 97 | Hypoplastic nipples (HP:0002557) | 1.97871659 |
| 98 | Bifid scrotum (HP:0000048) | 1.97775267 |
| 99 | Acute hepatic failure (HP:0006554) | 1.97739372 |
| 100 | Genetic anticipation (HP:0003743) | 1.97731740 |
| 101 | Blue irides (HP:0000635) | 1.97537573 |
| 102 | Abdominal distention (HP:0003270) | 1.96830655 |
| 103 | Broad nasal tip (HP:0000455) | 1.96160084 |
| 104 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.96130818 |
| 105 | Decreased circulating renin level (HP:0003351) | 1.95956582 |
| 106 | Sensorimotor neuropathy (HP:0007141) | 1.95376452 |
| 107 | Generalized hypopigmentation of hair (HP:0011358) | 1.94774317 |
| 108 | Metabolic acidosis (HP:0001942) | 1.94566737 |
| 109 | Relative macrocephaly (HP:0004482) | 1.94371772 |
| 110 | Elevated alkaline phosphatase (HP:0003155) | 1.93573347 |
| 111 | Abnormal foot bone ossification (HP:0010675) | 1.93322372 |
| 112 | Global brain atrophy (HP:0002283) | 1.92975330 |
| 113 | Arterial tortuosity (HP:0005116) | 1.92605467 |
| 114 | Advanced eruption of teeth (HP:0006288) | 1.92192051 |
| 115 | Back pain (HP:0003418) | 1.91760056 |
| 116 | Prostate neoplasm (HP:0100787) | 1.91476196 |
| 117 | Right ventricular cardiomyopathy (HP:0011663) | 1.90752911 |
| 118 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.90447389 |
| 119 | Termporal pattern (HP:0011008) | 1.90056885 |
| 120 | Insidious onset (HP:0003587) | 1.90056885 |
| 121 | Turricephaly (HP:0000262) | 1.89115169 |
| 122 | Long eyelashes (HP:0000527) | 1.88938895 |
| 123 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.88147623 |
| 124 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.87856964 |
| 125 | Fair hair (HP:0002286) | 1.87179107 |
| 126 | EEG with generalized epileptiform discharges (HP:0011198) | 1.86011056 |
| 127 | Lower limb hyperreflexia (HP:0002395) | 1.85569745 |
| 128 | Sandal gap (HP:0001852) | 1.85423086 |
| 129 | Abnormal tarsal ossification (HP:0008369) | 1.84071786 |
| 130 | Hypsarrhythmia (HP:0002521) | 1.83895867 |
| 131 | Abnormal gallbladder morphology (HP:0012437) | 1.83411744 |
| 132 | Scanning speech (HP:0002168) | 1.82277468 |
| 133 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.82118962 |
| 134 | Abnormal pancreas size (HP:0012094) | 1.81807071 |
| 135 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.81674959 |
| 136 | Glomerulonephritis (HP:0000099) | 1.80975545 |
| 137 | Subacute progressive viral hepatitis (HP:0006572) | 1.80600017 |
| 138 | Obstructive sleep apnea (HP:0002870) | 1.79866585 |
| 139 | Epileptiform EEG discharges (HP:0011182) | 1.79812168 |
| 140 | Capillary hemangiomas (HP:0005306) | 1.79288789 |
| 141 | Acanthocytosis (HP:0001927) | 1.78535143 |
| 142 | Abnormality of serum amino acid levels (HP:0003112) | 1.78365234 |
| 143 | Agitation (HP:0000713) | 1.78302717 |
| 144 | Cervical subluxation (HP:0003308) | 1.78283125 |
| 145 | Vertebral arch anomaly (HP:0008438) | 1.78215986 |
| 146 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.78213762 |
| 147 | Abnormality of the nasal septum (HP:0000419) | 1.77642844 |
| 148 | Tubulointerstitial nephritis (HP:0001970) | 1.76713691 |
| 149 | Vascular tortuosity (HP:0004948) | 1.76248067 |
| 150 | Abnormality of the parathyroid morphology (HP:0011766) | 1.76225016 |
| 151 | Menorrhagia (HP:0000132) | 1.76113055 |
| 152 | Gaze-evoked nystagmus (HP:0000640) | 1.76103540 |
| 153 | Papilledema (HP:0001085) | 1.75432798 |
| 154 | Laryngomalacia (HP:0001601) | 1.74507300 |
| 155 | Asymmetry of the thorax (HP:0001555) | 1.73943101 |
| 156 | Hypophosphatemia (HP:0002148) | 1.73483166 |
| 157 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.73167119 |
| 158 | Testicular neoplasm (HP:0010788) | 1.72867506 |
| 159 | Cystic hygroma (HP:0000476) | 1.72370286 |
| 160 | Open mouth (HP:0000194) | 1.71093018 |
| 161 | Aneurysm (HP:0002617) | 1.70738320 |
| 162 | Calf muscle hypertrophy (HP:0008981) | 1.70660611 |
| 163 | Low anterior hairline (HP:0000294) | 1.70585205 |
| 164 | Tapered finger (HP:0001182) | 1.68986674 |
| 165 | Impaired vibratory sensation (HP:0002495) | 1.68471839 |
| 166 | Hypoplastic labia majora (HP:0000059) | 1.67324192 |
| 167 | Hyperkalemia (HP:0002153) | 1.65164140 |
| 168 | Hypopigmentation of the fundus (HP:0007894) | 1.65121626 |
| 169 | Delayed CNS myelination (HP:0002188) | 1.65031529 |
| 170 | Ankyloglossia (HP:0010296) | 1.64450919 |
| 171 | Abnormality of the ischium (HP:0003174) | 1.64092480 |
| 172 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.63953742 |
| 173 | Broad face (HP:0000283) | 1.62364689 |
| 174 | Alkalosis (HP:0001948) | 1.62362107 |
| 175 | Depressed nasal tip (HP:0000437) | 1.62241749 |
| 176 | Hypophosphatemic rickets (HP:0004912) | 1.60497672 |
| 177 | Hypoplasia of the odontoid process (HP:0003311) | 1.60322164 |
| 178 | Rickets (HP:0002748) | 1.58972542 |
| 179 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.58643947 |
| 180 | Dicarboxylic aciduria (HP:0003215) | 1.58643947 |
| 181 | Mitral valve prolapse (HP:0001634) | 1.58593387 |
| 182 | Death in childhood (HP:0003819) | 1.57846397 |
| 183 | Systemic lupus erythematosus (HP:0002725) | 1.57737240 |
| 184 | Abnormality of chromosome segregation (HP:0002916) | 1.56102442 |
| 185 | Abnormality of the labia majora (HP:0012881) | 1.53946145 |
| 186 | Osteomalacia (HP:0002749) | 1.52164665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 5.11519273 |
| 2 | TAOK3 | 4.91529179 |
| 3 | BCKDK | 3.63476801 |
| 4 | CDK12 | 3.60913269 |
| 5 | FRK | 3.52954542 |
| 6 | ERN1 | 2.97935837 |
| 7 | SIK1 | 2.69706764 |
| 8 | MAP3K2 | 2.57436073 |
| 9 | MAPK15 | 2.42562876 |
| 10 | FGFR4 | 2.31601677 |
| 11 | TNK2 | 2.21479903 |
| 12 | EEF2K | 2.21179267 |
| 13 | BRD4 | 2.14428939 |
| 14 | LATS1 | 1.88805547 |
| 15 | EIF2AK3 | 1.58791326 |
| 16 | PASK | 1.58208437 |
| 17 | HIPK2 | 1.55972395 |
| 18 | IRAK3 | 1.54105193 |
| 19 | PTK6 | 1.51637073 |
| 20 | PDGFRA | 1.48598395 |
| 21 | FGFR2 | 1.45999536 |
| 22 | TRIB3 | 1.43867829 |
| 23 | PRKD3 | 1.43437936 |
| 24 | PIK3CG | 1.39809248 |
| 25 | ICK | 1.39706372 |
| 26 | EPHA3 | 1.37839593 |
| 27 | STK39 | 1.37541644 |
| 28 | MAP3K1 | 1.29989575 |
| 29 | WNK4 | 1.25298985 |
| 30 | NTRK1 | 1.23472120 |
| 31 | RIPK1 | 1.23321079 |
| 32 | CLK1 | 1.22852248 |
| 33 | NLK | 1.20511360 |
| 34 | YES1 | 1.18630122 |
| 35 | PRKCH | 1.17497456 |
| 36 | FLT3 | 1.17407760 |
| 37 | MAP3K3 | 1.16701726 |
| 38 | AKT3 | 1.15844952 |
| 39 | MAP2K4 | 1.14262109 |
| 40 | JAK1 | 1.10908511 |
| 41 | NTRK3 | 1.10218493 |
| 42 | IRAK1 | 1.09397616 |
| 43 | PAK3 | 1.09393427 |
| 44 | CDK6 | 1.08982945 |
| 45 | BRSK2 | 1.07869654 |
| 46 | RET | 1.05949141 |
| 47 | ERBB4 | 1.05082225 |
| 48 | FGFR3 | 1.02748423 |
| 49 | MST1R | 1.00596719 |
| 50 | CAMKK2 | 1.00324421 |
| 51 | PTK2 | 1.00153920 |
| 52 | CAMK1G | 0.97947766 |
| 53 | FER | 0.97717289 |
| 54 | NUAK1 | 0.95488505 |
| 55 | JAK2 | 0.93078408 |
| 56 | MET | 0.92308261 |
| 57 | EIF2AK1 | 0.92017804 |
| 58 | PKN2 | 0.91130438 |
| 59 | ERBB3 | 0.90651649 |
| 60 | DAPK2 | 0.90381289 |
| 61 | IRAK2 | 0.89262151 |
| 62 | NEK6 | 0.89174488 |
| 63 | CDC42BPA | 0.88882754 |
| 64 | BCR | 0.87249940 |
| 65 | EPHB1 | 0.83909846 |
| 66 | SGK3 | 0.79284558 |
| 67 | MAP3K4 | 0.78559236 |
| 68 | PDGFRB | 0.78453042 |
| 69 | PNCK | 0.76571786 |
| 70 | PIK3CA | 0.76425746 |
| 71 | CASK | 0.76322490 |
| 72 | PRKAA1 | 0.74036492 |
| 73 | CAMK1D | 0.73608073 |
| 74 | PRKAA2 | 0.72535597 |
| 75 | SGK2 | 0.70931413 |
| 76 | DYRK1B | 0.68532553 |
| 77 | WNK1 | 0.68302884 |
| 78 | STK3 | 0.67456474 |
| 79 | MAP3K7 | 0.65868615 |
| 80 | ACVR1B | 0.64096997 |
| 81 | KSR1 | 0.61889060 |
| 82 | CDK9 | 0.61675941 |
| 83 | MAPK10 | 0.60573318 |
| 84 | SGK494 | 0.60067590 |
| 85 | SGK223 | 0.60067590 |
| 86 | CAMK2D | 0.58926946 |
| 87 | DDR2 | 0.58179813 |
| 88 | ITK | 0.57351464 |
| 89 | PDPK1 | 0.57085393 |
| 90 | TRPM7 | 0.56737467 |
| 91 | CAMKK1 | 0.56142697 |
| 92 | SGK1 | 0.55710486 |
| 93 | CAMK2B | 0.51583293 |
| 94 | PRKD1 | 0.51178866 |
| 95 | PRKACG | 0.50863061 |
| 96 | PRKCE | 0.48863571 |
| 97 | SCYL2 | 0.48514662 |
| 98 | MAP2K1 | 0.48306415 |
| 99 | GSK3A | 0.48262847 |
| 100 | MTOR | 0.47619682 |
| 101 | MAPK13 | 0.47287015 |
| 102 | CAMK2G | 0.47088326 |
| 103 | IGF1R | 0.46645101 |
| 104 | LATS2 | 0.46275744 |
| 105 | TAOK1 | 0.45918862 |
| 106 | MAPK11 | 0.45018929 |
| 107 | UHMK1 | 0.43737197 |
| 108 | MAP2K2 | 0.43487719 |
| 109 | ATM | 0.43315102 |
| 110 | CSNK1E | 0.42563937 |
| 111 | CAMK4 | 0.42178388 |
| 112 | PDK1 | 0.40936950 |
| 113 | ERBB2 | 0.40838147 |
| 114 | CDK3 | 0.40316283 |
| 115 | MAP3K13 | 0.40228037 |
| 116 | GSK3B | 0.40101875 |
| 117 | RPS6KA2 | 0.39769380 |
| 118 | RAF1 | 0.38882866 |
| 119 | MAPK14 | 0.38816073 |
| 120 | PRKD2 | 0.38809185 |
| 121 | MELK | 0.38287100 |
| 122 | KSR2 | 0.37028998 |
| 123 | MAP3K10 | 0.36216536 |
| 124 | NEK9 | 0.35873980 |
| 125 | STK38 | 0.35642421 |
| 126 | CSK | 0.35466303 |
| 127 | MAPK1 | 0.34014291 |
| 128 | PRKCG | 0.33735613 |
| 129 | MKNK2 | 0.33226894 |
| 130 | DYRK1A | 0.32978339 |
| 131 | TNIK | 0.32843428 |
| 132 | CHEK1 | 0.32760526 |
| 133 | EIF2AK2 | 0.32554716 |
| 134 | TAF1 | 0.32484688 |
| 135 | PRKCQ | 0.31876765 |
| 136 | CAMK2A | 0.31280135 |
| 137 | RPS6KB1 | 0.30370269 |
| 138 | STK38L | 0.30248637 |
| 139 | CDK7 | 0.30055358 |
| 140 | MAPK8 | 0.29267681 |
| 141 | MARK2 | 0.28973633 |
| 142 | AKT1 | 0.28705296 |
| 143 | IRAK4 | 0.28554259 |
| 144 | PRKCZ | 0.28342204 |
| 145 | INSR | 0.27789369 |
| 146 | TTN | 0.27699160 |
| 147 | RPS6KA3 | 0.27639755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.32939895 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.39025208 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.98208585 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.53162385 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.52564334 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.47348886 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.41145526 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.35974126 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.19706464 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.14712245 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.06091936 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.98012631 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.95004933 |
| 14 | Protein export_Homo sapiens_hsa03060 | 1.74923732 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.73514206 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 1.63276667 |
| 17 | Prostate cancer_Homo sapiens_hsa05215 | 1.61762175 |
| 18 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58179040 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.57270996 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.56063925 |
| 21 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.53519023 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.53479466 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.52372385 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.50605960 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.49068923 |
| 26 | ABC transporters_Homo sapiens_hsa02010 | 1.47435096 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.46890748 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.46374954 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.44654441 |
| 30 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.40502566 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.39379557 |
| 32 | Thyroid cancer_Homo sapiens_hsa05216 | 1.31150153 |
| 33 | Endometrial cancer_Homo sapiens_hsa05213 | 1.29667079 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.28041022 |
| 35 | Insulin secretion_Homo sapiens_hsa04911 | 1.26768241 |
| 36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.26011262 |
| 37 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.23333900 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.22954349 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.21598934 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19944845 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.16158244 |
| 42 | Adherens junction_Homo sapiens_hsa04520 | 1.14817238 |
| 43 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.14788117 |
| 44 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.12563071 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.11541059 |
| 46 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.11361883 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.10781712 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.10525514 |
| 49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10504619 |
| 50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.10007968 |
| 51 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.08235985 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.02265035 |
| 53 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.00782710 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.00574959 |
| 55 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99779910 |
| 56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.96876261 |
| 57 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.95469325 |
| 58 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.94810058 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94056264 |
| 60 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.93017332 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.91734583 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 0.90305593 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.86864383 |
| 64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.84902521 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84184546 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.81338954 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79604255 |
| 68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78309575 |
| 69 | Glioma_Homo sapiens_hsa05214 | 0.77749651 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77586054 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76599177 |
| 72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.76499163 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76061310 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.74665865 |
| 75 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72348237 |
| 76 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.72066692 |
| 77 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.71794983 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.71759139 |
| 79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68958957 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68517030 |
| 81 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68149306 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.67719035 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66168347 |
| 84 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.65479647 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64984881 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64597981 |
| 87 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59982909 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59402507 |
| 89 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57890670 |
| 90 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.55015652 |
| 91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.54955713 |
| 92 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52654781 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.52136963 |
| 94 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50490809 |
| 95 | Renin secretion_Homo sapiens_hsa04924 | 0.50094150 |
| 96 | Carbon metabolism_Homo sapiens_hsa01200 | 0.47702652 |
| 97 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47445614 |
| 98 | Cocaine addiction_Homo sapiens_hsa05030 | 0.47156619 |
| 99 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.46760784 |
| 100 | Long-term potentiation_Homo sapiens_hsa04720 | 0.45661790 |
| 101 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.45265301 |
| 102 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43639463 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43614263 |
| 104 | Lysosome_Homo sapiens_hsa04142 | 0.42950337 |
| 105 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.42919484 |
| 106 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41477183 |
| 107 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39441139 |
| 108 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.39154168 |
| 109 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38418895 |
| 110 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.38191648 |
| 111 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38024601 |
| 112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37766166 |
| 113 | Focal adhesion_Homo sapiens_hsa04510 | 0.37683141 |
| 114 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.37671168 |
| 115 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.36980983 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36876684 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.36404569 |
| 118 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35959131 |
| 119 | Colorectal cancer_Homo sapiens_hsa05210 | 0.35551376 |
| 120 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.35322060 |
| 121 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.32866019 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32462833 |
| 123 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32324160 |
| 124 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31634366 |
| 125 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.31599438 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31385033 |
| 127 | Taste transduction_Homo sapiens_hsa04742 | 0.29839921 |
| 128 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.29497092 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26185460 |
| 130 | GABAergic synapse_Homo sapiens_hsa04727 | 0.26140671 |
| 131 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25762092 |
| 132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.24632599 |
| 133 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.24233756 |
| 134 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24001177 |
| 135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.23725314 |
| 136 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.22712258 |
| 137 | Metabolic pathways_Homo sapiens_hsa01100 | 0.22045579 |
| 138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20546205 |
| 139 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.19796238 |
| 140 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.18582573 |

